These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 6735091)

  • 1. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
    Dew MJ; Evans BK; Rhodes J
    Gastroenterology; 1984 Aug; 87(2):480-1. PubMed ID: 6735091
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 3. [New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].
    Kruis W
    Z Gastroenterol Verh; 1991 Mar; 26():154-6. PubMed ID: 1714132
    [No Abstract]   [Full Text] [Related]  

  • 4. Will there be a next generation of sulfasalazine?
    Goldman P
    Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 6. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease].
    Hartmann F
    Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
    Fahrländer H
    Schweiz Med Wochenschr; 1987 Oct; 117(42):1620-3. PubMed ID: 3321418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-amino-salicylic acid. A review of a new treatment of chronic inflammatory bowel disease].
    Rasmussen SN; Bondesen S; Nielsen OH; Binder V; Hansen SH; Hvidberg E
    Ugeskr Laeger; 1985 Sep; 147(36):2811-5. PubMed ID: 4071726
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New developments in the treatment of inflammatory bowel diseases. What is certain?].
    Feurle GE
    Z Gastroenterol Verh; 1990 Apr; 25():150-2. PubMed ID: 1694355
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE; Schraa CC
    Pharmacotherapy; 1994; 14(4):385-98. PubMed ID: 7937276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 18. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of recurrence of chronic inflammatory bowel diseases].
    Dölle W; Hartmann F
    Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.